Page 4 - Solara Active Pharma Sciences News Today

Solara Active Pharma Sciences Ltd today announced that its new state-of-the-art multipurpose API manufacturing facility at Visakhapatnam, Andhra Pradesh completed successfully the inspection carried out by the US FDA.

Solara Active Pharma Sciences Limited has successfully completed the inspection carried out by the World Health Organization at its Cuddalore facility, Tamil Nadu between January 23 – 26, 2023.

The Board of Directors of Solara Active Pharma Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

The Board of Directors of Solara Active Pharma Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23 and H1FY23.

Solara Active Pharma Sciences Ltd ha announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received Certificate of Suitability approval for the manufacture of Ibuprofen API, from EDQM.

New Delhi [India], October 3 (ANI/NewsVoir): Holiday Inn, Aerocity was the venue for interesting discussions on automation and HR's role in the digital-transformation process on September 29, 2022. The conference, aptly christened Automation.NXT - organised by HRKatha, and powered by Tata Steel Industrial Consulting, with UKG as workforce management partner, Onsurity as SME healthcare partner, NHRDN as community partner, and OpenOffers as lanyard partner - was the reason why so many great mi...

/PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Global Ibuprofen API Market" by Applications (Arthritis,...

The global Ibuprofen API Market surpassed US$ 626.2 Mn in 2022 and is anticipated to increase at a CAGR of 3% to reach US$ 772.2 Mn by 2029. as per the findings of a new Future Market Insights (FMI) study. The primary factors for the growth of the Ibuprofen API market include continuous demand for low-cost non-stero...

Following the heavy selling in the equity markets, the market value of BSE-listed firms retreated to Rs 245 lakh crore on June 28, 2022 from Rs 266 lakh crore on December 31 last year. 

Traders and investors alike have found it challenging to navigate the market amid the ongoing volatility